Five Prime Therapeutics (FPRX) Selloff Unfounded - Nomura/Instinet
Tweet Send to a Friend
Nomura/Instinet maintains Buy on Five Prime Therapeutics (NASDAQ: FPRX) price target of $94.00.Analyst Chris Marai defends the name noting durable ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


